{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Direct Oral Anticoagulants in Patients Cancer ((Non-Physician Credit))

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

The certificate for this activity is for NON-PHYSICIANS.

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Purpose of Activity

To provide information on the use of direct oral anticoagulants in cancer patients for venous thromboembolism (VTE) prophylaxis or treatment.

Learning Objectives

After completing this continuing education activity you will be able to:

Summarize findings from recent trials on the use of oral Factor Xa inhibitors in the prevention or treatment of cancer-associated thromboembolism.

Disclosures

The author, faculty, staff, and planners, including spouses/partners (if any), in any position to control the content of this CME/CNE activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies relevant to this educational activity.

Price: $10.00

Credits:

  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Other Health Professional
Test Code: OTN0419
Published: April 2019
Expires: 1/1/2026
Sources: Oncology Times
Required Passing Score: 7/10 (70%)
Authors: Lisa Lohr, PharmD, BCPS, BCOP
Categories: Cancer , Drug Therapy , Oncology
Specialties: Hematology, Oncology
Topics: Cancer , Oral Anticoagulants